OptimizeRx | 10-Q: Quarterly report
OptimizeRx | 8-K: OptimizeRx Reports First Quarter 2024 Financial Results
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Silvestro Stephen L
OptimizeRx | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Silvestro Stephen L
OptimizeRx | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Silvestro Stephen L
OptimizeRx | 8-K: Current report
OptimizeRx | ARS: Annual Report to Security Holders
OptimizeRx | DEF 14A: Definitive information statements
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer FEBBO WILLIAM J
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Besch Doug
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Odence-Ford Marion
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Stelmakh Edward
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Silvestro Stephen L
OptimizeRx | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Stelmakh Edward
OptimizeRx | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Stelmakh Edward
OptimizeRx | 8-K: OptimizeRx Reports Strong Fourth Quarter a nd Full Year 2023 Financial Results
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer FEBBO WILLIAM J
OptimizeRx | 10-K: Annual report
OptimizeRx | 8-K: Current report
OptimizeRx | NT 10-K: Others
No Data